Nevada Cancer Institute Dept. of Nevada Cancer (3) — Las Vegas, Nevada

Nevada Cancer Institute Dept. of Nevada Cancer (3) is a clinical research site located in Las Vegas, Nevada, United States 89135.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Nevada Cancer Institute Dept. of Nevada Cancer (3) has participated in 2 clinical trials.

Therapeutic areas: HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer, Carcinoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nevada Cancer Institute Dept. of Nevada Cancer (3)?

Nevada Cancer Institute Dept. of Nevada Cancer (3) has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nevada Cancer Institute Dept. of Nevada Cancer (3) conducted?

Nevada Cancer Institute Dept. of Nevada Cancer (3) has 2 clinical trials on record. Their work covers HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer, Carcinoma.

Is Nevada Cancer Institute Dept. of Nevada Cancer (3) accredited by Crixeo Health?

Nevada Cancer Institute Dept. of Nevada Cancer (3) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nevada Cancer Institute Dept. of Nevada Cancer (3)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.